Romidepsin = 98 HPLC 128517-07-7 - Highly Potent Prodrug HDAC Inhibitor

REF #: 3199609
Procurenet
Short description

Romidepsin = 98 HPLC 128517-07-7 – Highly Potent Prodrug HDAC Inhibitor

  • 98% HPLC Romidepsin
  • Very potent natural prodrug inhibitor of HDAC1 and HDAC2
  • Antineoplastic drug
$0
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only
Description

Romidepsin = 98 HPLC 128517-07-7 - Highly Potent Prodrug HDAC Inhibitor

Romidepsin (CAS Number: 128517-07-7) is a highly potent natural prodrug inhibitor of HDAC1 and HDAC2. It is commonly used in the field of oncology as an antineoplastic agent. With a purity of 98% as determined by HPLC analysis, Romidepsin offers a reliable and consistent solution for research and pharmaceutical purposes.

Chemical Formula: C24H36N4O6S2

Chemical Structure: Insert Chemical Structure Image Here

Features and Benefits:

  • Potency: Romidepsin is a highly potent inhibitor of HDAC1 and HDAC2, making it an effective therapeutic option for the treatment of cancer.
  • Prodrug: It acts as a prodrug, which means it is initially inactive and is converted to its active form within the body.
  • HDAC Inhibition: By inhibiting HDAC enzymes, Romidepsin causes histone hyperacetylation, leading to changes in gene expression and ultimately inducing cell cycle arrest and apoptosis.
  • Antineoplastic Activity: Romidepsin exhibits potent antineoplastic activity, making it a promising pharmaceutical candidate for the treatment of various cancers.
  • High Purity: Romidepsin is supplied with a purity of 98% as determined by HPLC analysis, ensuring consistent and reliable results in research and pharmaceutical applications.

Applications:

Due to its potent HDAC inhibitory activity and antineoplastic properties, Romidepsin finds applications in the following areas:

  • Cancer Research: Romidepsin is commonly used in cancer research studies to investigate its effects on different cancer cell lines and to explore its potential as a therapeutic agent.
  • Pharmaceutical Development: Romidepsin is a promising candidate for the development of novel anticancer drugs. Its unique mechanism of action and high potency make it an attractive target for pharmaceutical companies.
  • Clinical Trials: Romidepsin is being evaluated in clinical trials for the treatment of various types of cancer, including T-cell lymphoma, cutaneous T-cell lymphoma, and solid tumors.

Handling and Storage:

Romidepsin should be handled with caution. It is recommended to wear appropriate protective clothing, gloves, and eye protection when working with this compound. It should be stored in a cool, dry place, away from direct sunlight and sources of ignition.

References:

1. Insert Reference 1

2. Insert Reference 2

All categories
Filters